Details for New Drug Application (NDA): 021674
✉ Email this page to a colleague
The generic ingredient in MENOSTAR is estradiol. There are seventy-five drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the estradiol profile page.
Summary for 021674
Tradename: | MENOSTAR |
Applicant: | Bayer Hlthcare |
Ingredient: | estradiol |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 021674
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SYSTEM;TRANSDERMAL | Strength | 0.014MG/24HR | ||||
Approval Date: | Jun 8, 2004 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 021674
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bayer Hlthcare | MENOSTAR | estradiol | SYSTEM;TRANSDERMAL | 021674-001 | Jun 8, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
Bayer Hlthcare | MENOSTAR | estradiol | SYSTEM;TRANSDERMAL | 021674-001 | Jun 8, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
Bayer Hlthcare | MENOSTAR | estradiol | SYSTEM;TRANSDERMAL | 021674-001 | Jun 8, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription